AACR IO Webinar

TUMOR MUTATIONAL BURDEN, HETEROGENEITY, AND THE EFFICACY OF IMMUNOTHERAPY

February 4, 2025
11 a.m. -12:30 p.m. ET
VIRTUAL

Register

As the AACR IO 2025 conference approaches, the Scientific Committee has organized several webinars to be held before and after the conference. These free webinars reflect the broad scope of the program and the growing interest in immuno-oncology within the scientific community. Everyone is invited to join these sessions and actively participate in the discussions.

Moderator

Sergio A. Quezada, University College London Cancer Institute, London, United Kingdom

Panelists

• What Will It Take To Realize The Success Of Therapeutic Cancer Vaccines?
  Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
• Paul F. Robbins, National Cancer Institute (NCI), Bethesda, Maryland
• Genetic Intratumour Heterogeneity and Cancer Immunogenicity
  Marco Gerlinger, Queen Mary University of London (QMUL), London, UK and affiliated with King’s College London, London, United Kingdom
• Targeting the microbiome to promote health and end cancer
  Jennifer Wargo, University of Texas MD Anderson Cancer Center, Houston, Texas

Join our esteemed panelists as they discuss:

• Impact of mutational heterogeneity on the efficacy of immunotherapy.
• Importance of tumor mutational burden in cancer immunotherapy.
• Clonal heterogeneity and response to immunotherapy.
• Induction of mutagenesis and impact on tumor immunogenicity and treatment efficacy.